DARE BIOSCIENCE ($DARE) posted quarterly earnings results for Q1 2026 on Thursday, May 14th. The company reported earnings of -$0.20 per share, beating estimates of -$0.30 by $0.10. The company also reported revenue of $150,000, missing estimates of $1,004,363 by $-854,363.
Stock price change since market close: +2.5%
You can see Quiver Quantitative's $DARE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DARE BIOSCIENCE Hedge Fund Activity
We have seen 13 institutional investors add shares of DARE BIOSCIENCE stock to their portfolio, and 11 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 128,156 shares (+32.5%) to their portfolio in Q4 2025, for an estimated $247,341
- RENAISSANCE TECHNOLOGIES LLC removed 39,600 shares (-67.2%) from their portfolio in Q4 2025, for an estimated $76,428
- TWO SIGMA INVESTMENTS, LP added 33,036 shares (+inf%) to their portfolio in Q4 2025, for an estimated $63,759
- UBS GROUP AG added 22,448 shares (+107.3%) to their portfolio in Q1 2026, for an estimated $40,855
- US BANCORP \DE\ added 20,920 shares (+inf%) to their portfolio in Q4 2025, for an estimated $40,375
- VIRTU FINANCIAL LLC removed 19,200 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $34,944
- TWO SIGMA ADVISERS, LP added 17,900 shares (+inf%) to their portfolio in Q4 2025, for an estimated $34,547
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
